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Objective: This study examined the effect of acute ischemic stroke (AIS) care coordination between vascular surgery
and stroke neurology services with primary focus on acute patient stabilization and expeditious carotid endarterec-
tomy (CEA).
Methods: A standardized AIS protocol was instituted between vascular surgery and stroke neurology services in an
academic hospital (group I) that included: (1) rapid patient evaluation and imaging inclusive of brain and carotid
computed tomography/magnetic resonance angiography, carotid duplex ultrasound imaging or conventional arterio-
gram, or both; (2) patient admission to a dedicated stroke unit with minimum 1:2 intensive care nurse-to-patient stafﬁng
and a 24-hour available neurointensivist; (3) treatment of all patients with ipsilateral moderate or severe carotid stenosis
by CEA with cervical block (158 [81%]) or general anesthesia (38 [19%]). Patient exclusion from undergoing expeditious
CEA included (1) stroke in evolution, and (2) dense neurologic deﬁcit or National Institutes of Health Stroke Scale score
>15 (severe), or both. Comparisons of data were performed between group I patients and those treated in outlying
hospitals (group II) for similar indications. All data were prospectively collected in a computerized database and outcomes
evaluated retrospectively.
Results: From November 2002 to November 2012, 369 patients underwent CEA for AIS #1 week of presentation. There
were 192 patients in group I and 177 in group II. There were no differences in group I and II in mean stroke-to-CEA
interval (3.4 vs 3.9 days) or in the performance of eversion CEA (94% vs 97%), respectively. Intraoperative shunt use was
greater in group I (28%) than in group II (18%; P [ .021). Fewer total neurologic events (stroke or transient ischemic
attack) occurred in group I (6 [3.1%] vs 14 [7.3%]; P [ .03). No patients died in either group. Postoperative National
Institutes of Health Stroke Scale scores available in group I patients showed improvement from preoperative baseline in
mild and moderate stroke patients (P < .001).
Conclusions: In patients with stable acute stroke, early CEA is feasible and relatively safe. Stroke or death occurs in only
1%, and most complications are of nonfatal cardiac origin. A standardized stroke team protocol that is inclusive of stroke
neurologists and vascular surgeons allows for expeditious and safe CEA in the setting of an acute stroke. (J Vasc Surg
2014;60:85-91.)In several recent reports, standardization of care and
coordination of allied services have been shown to have a
beneﬁcial effect on the delivery of clinical care of complex
medical issues such as heart failure and craniofacial anoma-
lies.1-3 The complexity of patients presenting with acute
stroke secondary to extracranial carotid occlusive disease
lends itself to such a logical plan.4 In previous studies we,
as well as several other centers, have shown the efﬁcacy and
safety of early carotid endarterectomy (CEA) after recent
stroke.4-8 However, this patient population may have
poorer outcomes if appropriate diagnostic and perioperativeThe Institute for Vascular Health and Disease, Albany Medical
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sent study, we examined the results of a coordinated
approach to the care of these patients to examine the effect
on patient outcomes at our academic center (Albany Med-
ical Center [AMC]) compared with outlying hospitals with
no acute stroke protocols.
METHODS
A standardized protocol for the clinical care and treat-
ment of all patients presenting at AMC, a single academic
institution, with acute strokes secondary to ipsilateral extra-
cranial carotid-based occlusive lesions was established in
2002. This protocol involved a coordination of care be-
tween the vascular surgery and the acute stroke neurology
services. Stroke was deﬁned as onset of symptoms that per-
sisted >24 hours or ﬁndings of stroke on neuroimaging, or
both. Transient ischemic attack (TIA) was deﬁned as
stroke-like symptoms that fully resolved in <24 hours.
Patients were identiﬁed by the hospital transfer center
and the vascular surgery or stroke service was contacted
to accept the patient for hospital admission. Patients
were initially evaluated in the emergency department and
subsequently admitted to a dedicated neurology inten-
sive care unit (neuro-ICU) or a neuroprogressive unit
(NPU) equipped with at minimum 1:2 nurse-to-patient85
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ing patient care.
Diagnostic evaluation was performed on admission and
involved clinical assessment and calculation of National
Institute of Health Stroke Scale (NIHSS) Score.11 Brain
imaging was performed with head computed tomography
(CT) and diffusion-weighted magnetic resonance imaging
(MRI) studies to rule out hemorrhage and evaluate for
an ischemic stroke.
If patients did not have an intracerebral hemorrhage
and were seen #3 hours of stroke symptoms, treatment
with intravenous (IV) recombinant tissue plasminogen
activator (rt-PA) was administered. Thrombolysis was per-
formed in patients who presented >3 but <4.5 hours after
onset of stroke, were aged <80 years, and had no history of
stroke or diabetes. Subsequently, carotid duplex and CT
angiography (CTA) of the neck and head was performed.
Most patients underwent CTA in the emergency depart-
ment at the time of their initial presentation.
Routine transthoracic echocardiography was also per-
formed to evaluate for other possible sources of embolus.
If there was any discrepancy between arterial imaging
studies, catheter-directed angiography was obtained and
preferentially performed by the vascular surgery service.
In all patients with acute ischemic stroke (AIS) found
with a hemodynamically signiﬁcant (>50%) carotid stenosis
and neuroimaging that was negative for hemorrhage, com-
bination antiplatelet therapy and anticoagulation with IV
heparin was given. At AMC, anticoagulation is used preop-
eratively to treat a potential embolic source from the ipsi-
lateral carotid artery. Most consultations made to vascular
surgery in patients who were eligible were made soon after
presentation to the emergency department.
Patients at AMC were subsequently referred to the
vascular surgery service for treatment (group I) when there
was an ipsilateral internal carotid artery stenosis of $50%.
Exclusion criteria for vascular surgery were dense neuro-
logic deﬁcit with obtundation or dense hemiparesis,
NIHSS >15, or stroke in evolution.
In addition, data were collected from the other nonac-
ademic hospitals within our practice also performing CEA
for acute stroke #7 days during the same period (group
II) by the same set of vascular surgeons. In these hospitals,
there were no acute stroke neurology services and no sys-
tems of multidisciplinary management.
Most patients in groups I and II underwent preferential
cervical block anesthesia while awake. Preoperative anes-
thetic evaluation was limited to cardiac risk assessment.
Aside from the tests mentioned above to evaluate cardiac
sources of emboli, routine clinical cardiac consultation
and electrocardiography was obtained in all patients in
groups I and II.
Vascular surgery procedures were performed once
neurologic recovery had plateaued. Once patients were
identiﬁed as such, CEA was performed without delay.
Intraoperatively, eversion endarterectomy of the extracra-
nial carotid artery was performed preferentially according
to the techniques previously described.12 Procedureswere performed with the patient awake under cervical
block or under general anesthesia, according to surgeon
or patient preference. Anticoagulation was not reversed
or stopped preoperatively. Intraluminal shunts were placed
electively or on demand for neurologic deterioration.
Postoperatively, patients were cared for in the NPU or
neuro-ICU for hemodynamic monitoring, blood pressure
control, and evaluation for stroke exacerbation. All patients
with postoperative neurologic deﬁcits were evaluated clini-
cally and with brain imaging. Anticoagulation was discon-
tinued postoperatively unless there was a suspected other
embolic source of stroke or other clinical indication for
anticoagulation such as atrial ﬁbrillation (American Heart
Association guidelines). All patients were evaluated perio-
peratively by physical, occupational, and speech therapy
services for in-hospital and subsequent posthospitalization
rehabilitation needs.
Data, including patient demographics, time to surgery,
operative parameters, and patient outcomes, were collected
in a prospective database and retrospectively analyzed.
Postoperative stroke exacerbation was deﬁned as a deterio-
ration in neurologic status lasting >24 hours conﬁrmed by
neurology consultant examination or extension of previous
infarct or new ipsilateral infarct on brain imaging, or both.
In group I, a change in NIHSS score >4 points was also
used as a measure of stroke exacerbation. Postoperative
TIA was deﬁned as a focal ipsilateral neurologic deﬁcit
lasting <24 hours with no new ﬁnding on a diffusion-
weighted MRI study. Cardiac complications were identi-
ﬁed clinically by cardiology consultants and by analysis of
postoperative cardiac enzymes and electrocardiograms or-
dered selectively.
Statistical comparisons were performed using the Stu-
dent paired t-test for interval data and the c2 or the Fisher
exact test analysis for ordinal data, with the Bonferroni
correction applied when multiple comparisons were per-
formed on the same data. Signiﬁcance was accepted at
the level of P < .05.
RESULTS
During the 10-year period between November 2002
and November 2012, 3052 patients were admitted to
AMC with a diagnosis of AIS. Within this same period,
6476 patients underwent CEA for severe extracranial
occlusive disease at all hospitals covered by The Vascular
Group. Within this group, 2248 procedures were per-
formed at AMC. The indications for operation were stroke
in 319 of these patients (14%). As a result of this protocol,
192 patients (60%) at AMC were evaluated, treated, and
referred to vascular surgery by the acute stroke neurology
service for surgical evaluation and treatment with CEA
(group I). All patients referred to the vascular service in
group I by the stroke neurology service had internal carotid
artery stenosis >50%.
Six patients with operable and indicated disease were
not referred. In four of these patients, a hemorrhagic
component to the infarct was noted on MRI. These
patients underwent CEA after 1 month. One patient had
Table I. Patient demographics
Variables
Group Ia
(n ¼ 192)
Group IIa
(n ¼ 177)
Sex
Male 119 (62) 100 (57)
Female 73 (38) 77 (43)
Diabetic 47 (24) 53 (30)
Active smoker 52 (27) 46 (26)
Hypertension 161 (84) 146 (82)
Coronary artery disease 94 (49) 82 (46)
Hyperlipidemia 128 (67) 129 (73)
Mean age (range), years 71 (32-95) 72 (41-91)
Group I, Patients treated in academic medical center; Group II, patients
treated in outlying hospitals.
Data are presented as number (%) unless otherwise indicated.
aThe P values for comparisons between groups were not signiﬁcant.
Table II. Operative variables
Parameter
Group Ia
(n ¼ 192)
Group IIa
(n ¼ 177)
Endarterectomy
Eversion 185 (96) 171 (97)
Standard 7 (4) 6 (3)
Anesthesia
Cervical block 156 (81) 162 (92)
General 36 (19) 15 (8)
Block to general 1 1
Elective shunt 41 (21) 17 (10)
Cervical block 23 11
General anesthesia 18 6
Shunt on demand 13 (7) 14 (8)
Mean time from presentation
to CEA, days
3.4 3.9
CEA, Carotid endarterectomy; Group I, patients treated in academic
medical center; Group II, patients treated in outlying hospitals.
Data are presented as number (%) unless otherwise indicated.
aThe P values for comparisons between groups were not signiﬁcant.
Table III. Nonfatal postoperative complications
(2002-2012)
Parameter
Group I
(n ¼ 192),
No. (%)
Group II
(n ¼ 177),
No. (%) P
Total neurologic events 6 (3) 14 (7) .03a
Stroke exacerbation 2 (1) 6 (3) NS
Transient neurologic deﬁcit 4 (2) 8 (4) NS
Cardiac 10 (5) 1 (1) .007a
Pulmonary 0 2 (1) NS
Intracerebral bleed 1 (1) 0 NS
Wound bleeding/hematoma 10 (5) 5 (3) NS
Immediate ICA occlusion 1 (1) 2 (1) NS
Group I, Patients treated in academic medical center; Group II, patients
treated in outlying hospitals; ICA, internal carotid artery; NS, not
signiﬁcant.
aStatistically signiﬁcant (P < .05).
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1 month. The remaining patient had an acute myelocytic
leukemia and atrial dysrhythmia and was treated with anti-
coagulation only.
During the same time, 4228 patients underwent CEA
procedures at other hospitals covered by The Vascular
Group. Indications for operation were stroke in 396 pa-
tients (9%). A total of 177 patients (45%) underwent
CEA at other hospitals within our practice for acute stroke
#7 days (group II). No acute care stroke neurology ser-
vices were available in these outlying hospitals. Patient
demographics of these two groups are reported in
Table I. There were no signiﬁcant differences in demo-
graphics between the two groups.
Preoperative studies to assess the severity of stenosis in
groups I and II included ultrasound only (16% vs 31%), a
combination of ultrasound and angiographic imaging,
including CTA, MRA or catheter-based angiography
(79% vs 64%), and angiographic imaging only (3% vs 3%,
respectively). Calculations using a 3  2 c2 matrix showedthere was a statistically signiﬁcant difference in the use of
imaging modalities between groups I and II, (3  2
c2 ¼ 11.84; P ¼ .003), with more ultrasound studies per-
formed in group II. We then performed suitable individual
2  2 c2 analysis using the Bonferroni correction. There
was a preferential use of ultrasound only compared with
any other modality in group II (31%) vs group I (16%;
P ¼ .003) and preferential use of ultrasound with an addi-
tional angiographic imaging compared with either modality
alone to conﬁrm stenosis in group I vs group II (P ¼ .002).
Mean stenosis was not different in those treated, with 84%
stenosis (range, 50%-100%) in group I and 85% stenosis
(range, 50%-100%) in groups II.
Once referred to the vascular service, these patients
preferentially underwent CEA #24 hours. The interproce-
dural delay between stroke onset and performance of CEA
was similar between the two groups. Our preference in all
sites was to perform CEA with the eversion endarterectomy
technique (Table II). Cervical block was used for the pro-
cedures in most patients. General anesthesia was used when
patient discomfort or anticipated lack of cooperation dur-
ing the procedure precluded neurologic evaluation in the
awake patient. Although more patients underwent CEA
with cervical block in group II vs group I, these differences
were not statistically signiﬁcant.
A greater number of shunts (elective and emergency)
was placed group I than in II (54 [28%] vs 31 [18%]);
(c2 ¼ 5.27, P ¼ .021). This was mainly due to the propor-
tion of shunts placed electively, which was greater in group
I (P < .01). Although the proportion of patients shunted
electively was similar between group I and II (18 [50%]
vs six [40%]), more patients in group I received electively
shunts under cervical block (23 [15%] vs 11 [7%]). This
was statistically signiﬁcant (c2 ¼ 4.38, P ¼ .036).
There were no deaths in group I or II. Nonfatal com-
plications are listed in Table III. More nonfatal cardiac
complications occurred in group I (P < .05). The number
of total neurologic events during the 10-year period was
less in group I patients than in group II patients
(6 [3.1%] vs 14 [7.3%]; P < .05). The TIA or stroke
Table IV. Nonfatal neurologic complications (2002-2007)
Parameter
Group I
(n ¼ 89),
No. (%)
Group II
(n ¼ 83),
No. (%) P
Total neurologic events 3 (3) 8 (10) .085
Stroke exacerbation 2 (2) 2 (2) NS
Transient neurologic deﬁcit 1 (1) 6 (7) .04a
Group I, Patients treated in academic medical center; Group II, patients
treated in outlying hospitals; NS, not signiﬁcant.
aStatistically signiﬁcant (P < .05).
Table V. Nonfatal neurologic complications (2007-2012)
Parameter
Group I
(n ¼ 103),
No. (%)
Group II
(n ¼ 94),
No. (%) P
Total neurologic event rate 3 (3) 6 (6) NS
Stroke exacerbation 0 4 (4) .0501
Transient neurologic deﬁcit 3 (3) 2 (2) NS
Group I, Patients treated in academic medical center; Group II, patients
treated in outlying hospitals; NS, not signiﬁcant.
Table VI. National Institutes of Health Stroke Severity
Scale (NIHSS) scores in group I (2002-2012)
NIHSS score
Group I (n ¼ 152),
mean 6 SEM
Initial score 2.54 6 0.20
After treatment 1.50 6 0.16
Difference 1.05 6 0.10
Group I, Patients treated in academic medical center; SEM, standard error of
the mean.
Table VII. National Institutes of Health Stroke Severity
(NIHSS) scores in group I (2002-2012) according to
severity
NIHSS score
Mild stroke (1-4)
(n ¼ 125),
Moderate stroke (5-15)
(n ¼ 27),
mean 6 SEM mean 6 SEM
Initial score 1.66 6 0.12 6.63 6 0.42
Post-treatment score 0.89 6 0.12 4.33 6 0.42
Difference 0.78 6 0.12 2.30 6 0.50
SEM, Standard error of the mean.
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between the groups.
We examined the data from the two consecutive 5-year
periods and found that in the ﬁrst 5-year period there were
less total postoperative neurologic events that were largely
attributed to a greater number of transient deﬁcits in the
group II patients (Tables IV and V). In the most recent
5 years, the total neurologic event rate was still less in
group I due to no stroke exacerbations but was not statis-
tically signiﬁcant.
Regardless of group, in all patients with a shunt placed,
there were 3.5% postoperative stroke exacerbations (three
of 85), not signiﬁcantly different from 2.7% (ﬁve of 184)
in nonshunt patients (P ¼ .71 by Fisher exact test). Among
shunted patients, there was no statistically signiﬁcant differ-
ence in the stroke exacerbations in group I (1.9% [one of
54]) vs group II (6.5% [two of 31]; P ¼ .55 by Fisher exact
test). Among nonshunted patients, there was no statistically
signiﬁcant difference in the stroke incidence in group I (0.7%
[one of 138]) vs group II (2.7% [four of 146]; P ¼ .37 by
Fisher exact test).
Considering total postoperative neurologic events
(TPNE; stroke exacerbation or TIA) and regardless of
group, in patients with a shunt placed there were 7.1%
TPNE (six of 85), not signiﬁcantly different from 7.6%
(14 of 184) in nonshunt patients (P ¼ 1 by Fisher exact
test). Considering the different groups, there was no statis-
tically signiﬁcant difference in the TPNE in group I (5.6%
[three of 54]) vs group II (9.7% [three of 31]; P ¼ .66 by
Fisher exact test). Among nonshunted patients, there was
no statistically signiﬁcant difference in TPNE in group I
(2.2% [three of 138]) vs group II (7.5% [11 of 146];
P ¼ .053 by Fisher exact test).
Because the number of electively placed shunts was
greater in group I, we examined the effect of shuntplacement on the subsequent development of TPNE or
stroke exacerbation. In patients with elective shunt place-
ment, there were no strokes exacerbations and one TIA
in group I vs no stroke exacerbations or TIA in group
II, which was not signiﬁcant by Fisher exact test. In
patients with no shunt placed, one stroke exacerbation
and one TIA occurred in group I vs four strokes exacerba-
tions and six TIAs in group II. These occurrences were
also not signiﬁcantly different in terms of development of
TPNE (P ¼ .08 byFisher exact test) or stroke exacerbation
alone (P ¼ .37).
We also evaluated the results after lytic therapy for
acute stroke in patients who were subsequently referred
for CEA in group I. During the study period, 11 group I
patients (5.7%) received IV rt-PA infusion before CEA.
No postoperative TIAs or stroke exacerbations occurred in
this group. All neurologic events happened in the group I
patients who did not receive rt-PA (1.1% [two of 181] stroke
exacerbation and 3.3% [six of 181] stroke or TIA). These
differences were not signiﬁcant by the Fisher exact test.
The data on NIHSS score were available only in group
I patients. These scores were recorded at the initial assess-
ment and at the post-treatment neurologic assessment.
NIHSS scores were available preoperatively in 174 group
I patients (91%; NIHSS range, 1-13; mean, 2.86 6 0.21)
and after treatment in 153 patients (NIHSS range, 1-7;
mean, 1.50 6 0.16). In 152 patients, pretreatment and
post-treatment scores were both available, as reported in
Table VI. There was a signiﬁcant reduction in the scores af-
ter treatment (P < .001 by paired t-test). NIHSS scores
were stratiﬁed into two categories: mild (range, 1-4) and
moderate (range, 5-15; Table VII). Changes in both cate-
gories were highly signiﬁcant (P < .001 by paired t-test),
JOURNAL OF VASCULAR SURGERY
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stroke category (P ¼ .006 by unpaired t-test).
DISCUSSION
The rationale for early CEA after stroke has been
debated in the past, with some centers recommending
that treatment should not be performed with a stroke-to-
surgery interval of <30 days to 6 weeks.13 Most of these
data were published in reaction to poor results with CEA
in patients with dense deﬁcits.14,15 In recent years, several
centers have recommended CEA #1 month in patients
with stable stroke.5,6 Although the results of CEA have
improved, there is still trepidation regarding early CEA af-
ter stroke.16 Rockman et al16 reported a greater than three-
fold increase in postoperative stroke risk (9.4% vs 2.4%)
with CEA performed #1 month. Although these authors
recommended caution, there were no speciﬁc factors
within that study that helped deﬁne which patient might
be at risk for complications or might beneﬁt from earlier
surgery.
We have previously reported our results of 228 patients
undergoing CEA after acute stroke.17 In our prior study,
we found that the results of early CEA performed
#30 days in stroke exacerbation after CEA were similar
at all weekly intervening intervals. The results of this prior
study showed that some of this risk might be a conse-
quence of the initial infarct size, which correlated with
the risk of postoperative events. In support of this stance,
Rothwell et al,18 in an extensive review of 5893 patients
enrolled in the European Carotid Surgery and North
American Symptomatic Endarterectomy Trials, recommen-
ded CEA in the neurologically stable patient #2 weeks of
stroke to get the ideal beneﬁt.
Other centers have since also reported favorable results
with early CEA after acute stroke19-21:
Annambhotla et al19 found no signiﬁcant difference in
stroke, myocardial infarction, or death in patients undergo-
ing CEA at any interval between 2 to 90 days after onset of
preoperative symptoms. The ﬁndings in this study paral-
leled those in our prior study showing no difference in
stoke after CEA at any weekly interval of <1 month.
Ballotta et al20 performed CEA #2 weeks of stroke
(median of 8 days) in patients with modiﬁed Rankin scores
of #2. In this study, there were no postoperative strokes.
Aleksic et al21 compared CEA performed under cervi-
cal block #2 days vs 2 weeks after TIA or stroke and found
no difference and recommended early treatment.
Leseche et al22 evaluated patients presenting with
stroke in evolution, high-grade carotid stenosis, a median
interval to surgery of 6 days, with a median initial NIHSS
at admission of 8 days and found that CEA could be per-
formed safely. Functional outcomes were also improved
in these patients. The authors in this study recommended
standardized perioperative medical management and strict
blood pressure control.
Eckstein et al,23 however, performed CEA #6 weeks
after stroke, and although stroke rates were acceptable,
concluded that increased perioperative risk as measuredby American Society of Anesthesiologists class was a deter-
mining factor in the stroke risk and outcome.
In the present study, we evaluated the results of a stan-
dardized protocol in a single academic institution initially
conceived in 2000 and then fully implemented in 2002.
We had initially seen an improvement in the perioperative
outcomes of these patients once a dedicated stroke
neurology service with a full time stroke attending, neuro-
intensivist, NPU, and neuro-ICU was present. Referral for
surgery was based on strict clinical inclusion and exclusion
criteria. The vascular surgical operative technique was stan-
dardized and was performed by experienced surgeons who
performed a high volume of carotid surgery. The CEAs in
other hospitals were performed by surgeons within our
group who performed the operations in groups I and II
with similar technique and anesthetic choice and had surgi-
cal outcomes that were acceptable in terms of best practice,
stroke rates, and complications.4,24
The difference in neurologic event rates, we believe,
was due to the lack of a deﬁned management protocol,
dedicated stroke unit, speciﬁcally trained nursing staff,
and most importantly, qualiﬁed stroke neurology input.
However, we do accept that this difference may be due
to other factors such as patient selection and anesthetic
management during CEA. There was a higher proportion
of electively placed shunts in group I. Vascular fellows
and residents were involved in group I only, and it may
be construed that this inﬂuenced shunt placement and out-
comes; however, adverse neurologic outcomes in this study
were not related to shunt placement.
Most neurologists involved in the management of
acute stroke agree on the support and development of
acute stroke centers.4,9,10 A consensus statement from
The Brain Attack Coalition in the United States recom-
mended the development of comprehensive stroke cen-
ters (CSCs), recognizing them as distinct from primary
stroke centers, the latter determined only by the ability
to give rt-PA, whereas CSCs offer advanced stafﬁng,
infrastructure, and programs to stabilize and treat most
acute strokes. For certiﬁcation as a CSC, a stroke pro-
gram must be able to treat all strokes with dedicated
stroke service (24/7), neurosurgeon availability (24/7),
neuroendovascular team for thrombectomy/intra-
arterial thrombolysis, and dedicated neuro-ICU. The
stroke program at AMC meets the qualiﬁcation of a CSC
and was involved in treatment of patients in group I. In
addition, availability of vascular surgical/interventional
specialty services, state of the art imaging capability,
physical and occupational therapy, rehabilitation services,
and a committed academic institution with intensive care
and nursing care extend the care to meet the needs of
acute stroke patients. Most of the previous studies in
other institutions have shown superior results with
such resources.25,26 With appropriate resources, CEA
may be performed with good result after stroke in evo-
lution in concert with lytic therapy.27 The results of
CEA after rt-PA in the present study support ﬁndings
of prior studies.
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primary importance. We have discussed this extensively
with our stroke neurologists, and initially found ourselves
less aggressive in the timing of CEA, but over the years
have dramatically shortened the interval between stroke
diagnosis and surgery. The initial severity of stroke, as
measured by degree of clinical deﬁcit or more reliably by
scoring systems, such as the NIHSS, has played a key
part in such stratiﬁcation. NIHSS has been shown to
strongly predict outcome in patients after stroke.28-32
This prompted our neurologic colleagues to not recom-
mend our performance of CEA in patients with severe
strokes and NIHSS scores >15, because higher scores are
associated with minimal patient beneﬁt and higher risk.
This is partly due to potential worsening of neurologic
symptoms associated with early CEA and severe strokes
or lack of beneﬁt in restoring ﬂow to a large area of stroke.
However, we have treated patients with moderate stroke
with NIHSS of up to 13; thus, the recommendations of
the present study apply to the management of mild and
moderate strokes.
The results of the treatment algorithm as deﬁned in
this study do show a statistically signiﬁcant trend toward
improvement in neurologic function after CEA with mini-
mal delay after stable stroke. This is important, because the
two goals we aim for in the performance of CEA are (1)
prevention of subsequent ipsilateral stroke and (2) restora-
tion of brain perfusion. The unexpected improvement in
NIHSS in our patients after CEA may be a result of the
earlier treatment of patients with acute stroke when the
ischemic penumbra may be inﬂuenced positively by im-
provements in such perfusion.
This study has some limitations. It is a retrospective
analysis, and the comparisons with outside hospitals may
be unfairly weighted by referral patterns in those institu-
tions. In addition, because there was no routine neurologic
stratiﬁcation by NIHSS in group II, these patients may
have been neurologically worse off on presentation and
may have as a result incurred more postoperative neuro-
logic events. However, the study by Eckstein et al,23 as
cited earlier, concluded that increased medical preoperative
risk should be associated with worse neurologic outcomes
after CEA, but the incidence of cardiac and other preoper-
ative risk factors in the present study was similar in both
groups. One would therefore have expected similar neuro-
logic events if preoperative risk was a major determining
factor. Also, the low rates of stroke in both groups allow
the possibility of a type 2 statistical error in the analyses per-
formed. Lastly, although the differences in NIHSS were
more dramatic in patients with moderate stroke, the
numbers are small; therefore, further study and greater
numbers of patients may allow a stronger conclusion.
CONCLUSIONS
The results of the present study show that in patients
with stable neurologic function after acute stroke, surgical
treatment with CEA can be performed #1 week of the
stroke onset with acceptable outcomes. The results ofsurgery are optimally achieved in the setting of a coordi-
nated protocol involving a dedicated stroke team, experi-
enced vascular surgeons, state of the art diagnostic
capability, dedicated acute stroke care unit, neuro-ICU,
and trained experienced nursing staff. This study further
emphasizes the need for the presence and standardization
of protocols for the advancement of treatment of AIS,
along with development of CSCs.
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and Dhiraj M. Shah, have made in the data collection, anal-
ysis, and production of this report.
AUTHOR CONTRIBUTIONS
Conception and design: PP, GB, MM, KD, SR, RD
Analysis and interpretation: PP, GB, MM, PF, KD, SR, RD
Data collection: PP, GB, MM, PF, KD, SR, RD
Writing the article: PP, GB, MM, SR, RD
Critical revision of the article: PP, GB, MM, PF, SR, RD
Final approval of the article: PP, GB, MM, KD, SR, RD
Statistical analysis: PP, GB, PF, MM, SR, RD
Obtained funding: Not applicable
Overall responsibility: PP
REFERENCES
1. Pang PS, Gheorghide M. A review of phase II acute heart failure
syndromes clinical trials. Heart Fail Clin 2011;7:441-50.
2. Whellan DJ, Hasselblad V, Peterson E, O’Connor CM, Schulman KA.
Metaanalysis and review of heart failure disease management random-
ized controlled clinical trials. Am Heart J 2005;149:722-9.
3. Strauss RP. The organization and delivery of craniofacial health ser-
vices: the state of the art. Cleft Palat Craniofac J 1999;36:189-95.
4. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ,
Demaerschalk BM, et al. Guidelines for the early management of
patients with acute ischemic stroke: A guideline for healthcare pro-
fessionals from the American Heart Association/American Stroke As-
sociation. Stroke 2013;444:870-947.
5. Piotrowski JJ, Bernhard VM, Rubin JR, McIntyre KE, Malone JM,
Parent FN 3rd, et al. Timing of carotid endarterectomy after acute
stroke. J Vasc Surg 1990;11:45-52.
6. Gasecki AP, Ferguson GG, Eliasziw M, Clagett GP, Fox AJ,
Hachinski V, et al. Early endarterectomy for severe carotid artery ste-
nosis after a non-disabling stroke: results from the North American
Symptomatic Carotid Endarterectomy Trial. J Vasc Surg 1994;20:
288-95.
7. Paty PSK, Darling RC III, Woratyla S, Chang BB, Kreienberg PB,
Shah DM. Timing of carotid endarterectomy in patients with recent
stroke. Surgery 1997;122:850-5.
8. Rerkasem K, Rothwell PM. Systematic review of the operative risks of
carotid endarterectomy for recently symptomatic stenosis in relation to
the timing of surgery. Stroke 2009;40:e564-72.
9. Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN,
Brass LM, et al. Recommendations for comprehensive stroke centers. A
consensus statement from the Brain Attack Coalition. Stroke 2005;36:
1597-618.
10. Norrving B. Editorial comment-Organized stroke care: the core of
effective stroke care provision. Stroke 2005;36:1616-8.
11. Lyden P, Rama R, Liu L, Emr M, Warren M, Marler J. National In-
stitutes of Health Stroke Scale certiﬁcation is reliable across multiple
venues. Stroke 2009;40:2507-11.
12. Shah DM, Darling RC 3rd, Chang BB, Kreienberg PB, Paty PS.
Carotid endarterectomy by eversion technique. Adv Surg 1999;33:
459-76.
JOURNAL OF VASCULAR SURGERY
Volume 60, Number 1 Paty et al 9113. Giordano JM, Trout HH 3rd, Kozloff L, DePalma RG. Timing of
carotid endarterectomy after stroke. J Vasc Surg 1985;2:250-4.
14. Rob C. Operation for acute completed stroke due to thrombosis of the
internal carotid artery. Surgery 1969;65:862-5.
15. Wylie EJ, Hein MF, Adams JE. Intracranial hemorrhage following
surgical revascularization for treatment of acute stroke. J Neurosurg
1964;21:212-5.
16. Rockman CB, Maldonado TS, Jacobowitz GR, Cayne NS, Gagne PJ,
Riles TS. Early carotid endarterectomy in symptomatic patients is
associated with poorer perioperative outcomes. J Vasc Surg 2006;44:
480-7.
17. Paty PS, Darling RC 3rd, Feustel PJ, Bernardini GL, Mehta M,
Ozsvath KJ, et al. Early carotid endarterectomy after acute stroke.
J Vasc Surg 2004;39:148-54.
18. Rothwell PM, Eliaziw M, Gutnikov SA, Warlow CP, Barnett HJ. Ca-
rotid Endarterectomy Trialists Collaboration. Endarterectomy for
symptomatic carotid stenosis in relation to clinical subgroups and
timing of surgery. Lancet 2004;363:915-24.
19. Annambhotla S, Park MS, Keldahl ML, Morasch MD, Rodriguez HE,
Pearce WH, et al. Early versus delayed carotid endarterectomy in
symptomatic patients. J Vasc Surg 2012;56:1296-302.
20. Ballotta E, Meneghetti G, Da Giau G, Manara R, Saladini M,
Baracchini C. Carotid endarterectomy within 2 weeks of minor
ischemic stroke: a prospective study. J Vasc Surg 2008;48:595-600.
21. Aleksic M, Rueger MS, Sobesky J, Heckenkamp J, Jacobs AH,
Brunkwall J. Immediate CEA for symptomatic carotid disease prefer-
ably performed under local anaesthesia is safe. Vasa 2007;36:185-90.
22. Leseche G, Alsac JM, Castier Y, Fady F, Lavallee PC, Mazighi M, et al.
Carotid endarterectomy in the acute phase of crescendo cerebral
transient ischemic attacks is safe and effective. J Vasc Surg 2011;53:
637-42.
23. Eckstein HH, Ringleb P, Dorﬂer A, Klemm K, Muller BT,
Zegelman M, et al. The carotid surgery for ischemic stroke trial: aprospective observational study on carotid endarterectomy in the early
period after ischemic stroke. J Vasc Surg 2002;36:997-1004.
24. North American Symptomatic Carotid Endarterectomy Trial Collabo-
rators. Beneﬁcial effect of carotid endarterectomy in symptomatic
patientswithhigh-gradecarotid stenosis.NEngl JMed1991;325:445-53.
25. Candelise L, Gattinoni M, Bersano A, Micieli G, Sterzi R, Morabito A.
Stroke-unit care for acute stroke patients: an observational follow-up
study. Lancet 2007;369:299-305.
26. Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit)
care for stroke. Conchrane Database Syst Rev 2001;3:CD000197.
27. Leseche G, Alsac JM, Houbbalah R, Castier Y, Fady F, Mazighi M,
et al. Carotid endarterectomy in the acute phase of stroke-in-evolution
is safe and effective in selected patients. J Vasc Surg 2012;55:701-7.
28. Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH,
Clarke WR, et al. Baseline NIH Stroke Scale score strongly predicts
outcome after stroke: a report of the Trial of Org 10172 in Acute
Stroke Treatment (TOAST). Neurology 1999;53:126-31.
29. Schelegel DJ, Tanne D, Demchuk AM, Levine SR, Kasner SE.
Multicenter rt-PA Stroke Survey Group. Prediction of hospital dispo-
sition after thrombolysis for acute ischemic stroke using the National
Institutes of Health Stroke Scale. Arch Neurol 2004;61:1061-4.
30. Schlegel D, Kolb SJ, Luciano JM, Tovar JM, Cucchiara BL,
Liebeskind DS, et al. Utility of the NIH Stroke Scale as a predictor of
hospital disposition. Stroke 2003;34:134-7.
31. Muir KW, Weir CJ, Murray GD, Povey C, Lees R. Comparison of
neurological scales and scoring systems for acute stroke prognosis.
Stroke 1996;27:1817-20.
32. Frankel MR, Morgenstern LB, Kwiatkowski T, Lu M, Tilley BC,
Broderick JP, et al. Predicting prognosis after stroke. A placebo group
analysis from the National Institute of Neurological Disorders and
Stroke rt-PA Stroke Trial. Neurology 2000;55:952-8.
Submitted Oct 10, 2013; accepted Jan 20, 2014.
